vofatamab (B-701)

News alerts, weekly reports and conference planners

Company:

Rainier Therap

Drug class:

FGFR3 inhibitor

Related drugs:

FGFR3 fusion	Urothelial Cancer	FGFR3 fusion	Urothelial Cancer	B-701 Sensitive: C3 – Early Trials B-701 Sensitive : C3	B-701 Sensitive: C3 – Early Trials B-701 Sensitive : C3
FGFR3 mutation	Urothelial Cancer	FGFR3 mutation	Urothelial Cancer	B-701 Sensitive: C3 – Early Trials B-701 Sensitive : C3	B-701 Sensitive: C3 – Early Trials B-701 Sensitive : C3

Associations
(2)